Team Europe

Overall EU global response to COVID-19 pandemic amounts to €46 billion from ‘Team Europe’, a joint action involving the EU, its Member States and European financial institutions.

These funds are helping partner countries:

  • address the health emergency
  • strengthen their health systems
  • put in place water and sanitation measures
  • mitigate the socioeconomic consequences of the pandemic

Global Health Summit

Global Health Summit At the Global Health Summit, G20 leaders committed to a series of actions to accelerate the end of the COVID-19 crisis everywhere and better prepare for future pandemics. The G20 underlined the importance of increased and diversified manufacturing and recognised the role of intellectual property in ensuring equity. The G20 clearly stressed the need to ensure equitable access to vaccines and to support low and middle-income countries.

Team Europe presented to the summit concrete contributions, including its work with industrial partners, which are manufacturing vaccines in Europe, to rapidly make available vaccine doses for low and middle-income countries. Team Europe aims at donating at least 200 million doses of vaccines to low and middle-income countries until the end of the year, in particular through COVAX. To boost manufacturing capacity in Africa and access to vaccines, medicines and health technologies, Team Europe launched on 21 May a €1 billion initiative.

Pledging marathon

video call

In May 2020, the Commission launched the Coronavirus Global Response – a pledging marathon to mobilise funds for research and the development of tests, treatments and vaccines.

With the goal of strengthening health systems and global recovery, donors from around the world committed close to €16 billion, including €1.4 billion from the Commission.

Access to COVID-19 Tools (ACT) Accelerator

The World Health Organization, the EU and global health organisations launched in April 2020 the Access to COVID-19 Tools (ACT) Accelerator. The aim is to:

  • accelerate development of COVID-19 vaccines, tests and treatments
  • ensure equitable global access to them
  • strengthen health systems

The ACT-Accelerator brings together governments, scientists, civil society, charities and global health organisations. €15.3 billion have been pledged so far to support its work.


COVID-19 Vaccines Global Access (COVAX) is a global initiative aimed at equitable access to COVID-19 vaccines led by Gavi, the Vaccine Alliance, the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI), alongside UNICEF, key delivery partner. It is the vaccine pillar of the ACT-Accelerator.

So far €8.4 billion have been pledged in support of COVAX.

Over €3 billion from the EU’s Team Europe is bringing us closer to COVAX’s objective of delivering at least 1.8 billion doses to lower income countries by the end of 2021.

EU vaccine-sharing mechanism

The EU vaccine-sharing mechanism allows 27 Member States to share EU purchased doses with third countries, including through COVAX.

The Commission has secured 4.6 billion doses from six vaccine producers for the EU, with the possibility to share with other countries, in particular the Western Balkans, the EU’s Neighbourhood and Africa.

Strengthening health systems

Laboratory workers testing coronavirus samples at the Pasteur Institute in Dakar

We need to make progress with global vaccination and prepare health systems for future pandemics, especially in the most vulnerable countries.

The EU has invested over €1.1 billion to strengthen health systems in 13 African countries:

Burkina Faso, Burundi, Central African Republic, Democratic Republic of Congo, Ethiopia, Guinea (Conakry), Guinea Bissau, Libya, Mauritania, Morocco, Nigeria, Sudan and Zimbabwe.

Vaccine exports

Throughout the pandemic, the EU has remained fair and open to the world. It has exported 50% of the vaccines produced in the EU.

Up to late August, 700 million doses of vaccines have been exported to more than 130 different countries in the world - as many as have been delivered to EU citizens.